Addex Therapeutics Ltd (ADXN) — Capital Reinvestment Ratio
Addex Therapeutics Ltd (ADXN) has a Capital Reinvestment Ratio of 0.07x as of December 2020, meaning it reinvests 0% of its operating cash flow ($704.85K) in capital expenditures ($48.09K). Check tangible net worth ratio of Addex Therapeutics Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Addex Therapeutics Ltd Capital Reinvestment Ratio (2018–2018)
This chart tracks Addex Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Addex Therapeutics Ltd generate cash.
Annual Capital Reinvestment Ratio for Addex Therapeutics Ltd (2018–2018)
Year-by-year Capital Reinvestment Ratio for Addex Therapeutics Ltd from 2018 to 2018. See ADXN cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.01x | $1.75 Million | $9.05K | — |